Log in to save to my catalogue

Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in se...

Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in se...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f3696b4c6ecc440da6815dc4b3d60ec7

Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

About this item

Full title

Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

Publisher

England: BioMed Central Ltd

Journal title

Current controlled trials in cardiovascular medicine, 2020-11, Vol.21 (1), p.927-2, Article 927

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

An amendment to this paper has been published and can be accessed via the original article.

Alternative Titles

Full title

Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f3696b4c6ecc440da6815dc4b3d60ec7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f3696b4c6ecc440da6815dc4b3d60ec7

Other Identifiers

ISSN

1745-6215

E-ISSN

1745-6215

DOI

10.1186/s13063-020-04877-z

How to access this item